Our findings implicated a possibility to cure the trigeminal neuralgia with a noninvasive targeting therapy instead of open-brain surgery in the future as long as we could block the IL-6/Piezo2 pathway. This evidence concerns the gene IL6 and trigeminal nerve disorder.